Market Research Logo

Organogenesis, Inc. - Product Pipeline Analysis, 2016 Update

Summary

Organogenesis, Inc. (Organogenesis) is a regenerative medicine company that concentrates on bioactive wound healing and soft tissue regeneration. The company’s products include Apligraf and Dermagraft. Its Dermagraft is used for the treatment of full-thickness diabetic foot ulcers which are greater than 6 weeks duration. Organogenesis’s Apligraf is used for the treatment of venous leg ulcers and diabetic foot ulcers. Its Dermagraft is indicated in conjunction with standard wound care regimens in patients with adequate blood supply to the involved foot. The company serves the areas of bio-active wound healing, oral regeneration and bio-surgery. Organogenesis is headquartered in Canton, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Organogenesis, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Organogenesis, Inc. Company Snapshot
Organogenesis, Inc. Company Overview
Organogenesis, Inc. Pipeline Products and Clinical Trials Overview
Organogenesis, Inc. – Pipeline Analysis Overview
Key Facts
Organogenesis, Inc. - Major Products and Services
Organogenesis, Inc. Pipeline Products by Development Stage
Organogenesis, Inc. Pipeline Products Overview
Dermagraft - Epidermolysis Bullosa
Dermagraft - Epidermolysis Bullosa Product Overview
Dermagraft - Rotator Cuff Repair
Dermagraft - Rotator Cuff Repair Product Overview
Dermagraft - Venous Leg Ulcers Repair
Dermagraft - Venous Leg Ulcers Repair Product Overview
VCT01
VCT01 Product Overview
Organogenesis, Inc. - Key Competitors
Organogenesis, Inc. - Key Employees
Organogenesis, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Organogenesis, Inc., Recent Developments
Nov 02, 2015: Apligraf Wound Healing Technology Becomes First Transplant Product to Receive Marketing Approval in Switzerland
Oct 08, 2015: Comparative Effectiveness Analyses Report Faster Healing Times, Improved Probability of Chronic Wound Closure with Apligraf and Dermagraft
Jul 22, 2015: Organogenesis Launches New PuraPly Products at the APMA 2015 Annual Scientific Meeting
Jun 22, 2015: Landmark New Data: Apligraf Closes Significantly More Diabetic Foot Ulcers in Half the Time When Compared to Epifix
Mar 26, 2015: Journal of Medical Economics Publishes Findings from Groundbreaking Research Demonstrating the Health Economic Benefits of Apligraf and Dermagraft
Feb 04, 2015: Organogenesis Announces MiMedx Has Dismissed its Frivolous Lawsuit
Dec 31, 2014: MiMedx Files Tortious Interference Lawsuit Against Organogenesis
Apr 30, 2014: Organogenesis to Present Large Retrospective Comparative Effectiveness Analysis and Health Economic Data in Chronic Wound Healing at The Symposium on Advanced Wound Care and Wound Healing Society Meeting
Apr 22, 2014: Organogenesis to Present New Dermagraft Data at the Symposium on Advanced Wound Care and Wound Healing Society Annual Meeting
Apr 22, 2014: Organogenesis to Present New Apligraf Data at the Symposium on Advanced Wound Care and Wound Healing Society Annual Meeting
Appendix Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Organogenesis, Inc. Pipeline Products and Clinical Trials Overview
Organogenesis, Inc. Pipeline Products by Equipment Type
Organogenesis, Inc. Pipeline Products by Indication
Organogenesis, Inc., Key Facts
Organogenesis, Inc., Major Products and Services
Organogenesis, Inc. Number of Pipeline Products by Development Stage
Organogenesis, Inc. Pipeline Products Summary by Development Stage
Dermagraft - Epidermolysis Bullosa - Product Status
Dermagraft - Epidermolysis Bullosa - Product Description
Dermagraft - Rotator Cuff Repair - Product Status
Dermagraft - Rotator Cuff Repair - Product Description
Dermagraft - Venous Leg Ulcers Repair - Product Status
Dermagraft - Venous Leg Ulcers Repair - Product Description
VCT01 - Product Status
VCT01 - Product Description
Organogenesis, Inc., Key Employees
Organogenesis, Inc., Other Locations
Organogenesis, Inc., Subsidiaries
List of Figures
Organogenesis, Inc. Pipeline Products by Equipment Type
Organogenesis, Inc. Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report